BriaCell Therapeutics Corp. Quarterly Return On Assets in % from Q3 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
BriaCell Therapeutics Corp. quarterly/annual Return On Assets history and growth rate from Q3 2022 to Q3 2024.
  • BriaCell Therapeutics Corp. Return On Assets for the quarter ending October 31, 2024 was -191 %, a 297% decline year-over-year.
  • BriaCell Therapeutics Corp. annual Return On Assets for 2024 was -44.7 %, a 28.8% increase from 2023.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -191 -143 -297% Aug 1, 2024 Oct 31, 2024
Q2 2024 -44.7 +18.1 +28.8% May 1, 2024 Jul 31, 2024
Q1 2024 -37.4 +13.3 +26.2% Feb 1, 2024 Apr 30, 2024
Q4 2023 -57.5 +0.56 +0.97% Nov 1, 2023 Jan 31, 2024
Q3 2023 -48.1 -47.2 -5041% Aug 1, 2023 Oct 31, 2023
Q2 2023 -62.7 May 1, 2023 Jul 31, 2023
Q1 2023 -50.6 Feb 1, 2023 Apr 30, 2023
Q4 2022 -58 Nov 1, 2022 Jan 31, 2023
Q3 2022 -0.94 Aug 1, 2022 Oct 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.